H.E.B Allergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
H.E.B Allergy Relief fexofenadine hydrochloride tablets (180mg) are being recalled nationwide due to out-of-specification results for impurity A found during stability testing. The affected product is available in 15, 30, and 45 count bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a labeling/specification issue rather than an active safety hazard with reported illness or injury. The failure relates to impurity specifications found during testing with no reported patient harm documented in the source text.
Plain-English summary
Perrigo Company PLC is recalling H.E.B Allergy Relief, Fexofenadine Hydrochloride 180mg tablets (24HR) due to failed impurities and degradation specifications. During stability testing, an out-of-specification result was obtained for impurity A.
The recall affects three package sizes: 15 count bottles (NDC 37808-571-22), 30 count bottles (NDC 37808-571-39), and 45 count bottles (NDC 37808-571-95). A total of 13,920 containers have been distributed nationwide in the USA.
Affected lot numbers and expiration dates are: 0HE2530 (Exp 12/31/2021), 0JE2407 (Exp 2/28/2022), 1BR0462 (Exp 10/31/2022), 0FR0460 (Exp 2/28/2022), and 0LR0363 (Exp 6/30/2022).
Consumers who have purchased this product should consult with a pharmacist or healthcare provider about whether they should stop using it and obtain a replacement.
The recalled product
- Product
- H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/Antihistamine packaged as a) 15 count bottle, NDC 37808-571-22, UPC 0 41220 53081 6; b) 30 count bottle, NDC 37808-571-39, UPC 0 41220 53082 3; c) 45 count bottle, NDC 37808-571-95, UPC 0 41220 53083 0; Ma
- Manufacturer
- Perrigo Company PLC
- Affected units
- 13,920
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot a) 0HE2530
- Exp 12/31/2021
- 0JE2407
- Exp 2/28/2022: b) 1BR0462
- Exp 10/31/2022 c) 0FR0460
- Exp 2/28/2022: 0LR0363
- Exp 6/30/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · impurity specification
See all →- ModerateLorazepam injection vials failed the total related compounds impurity specification
FDA (Drugs) · 2025-08-06
- ModeratePitavastatin tablets recalled after failing impurity and degradation specifications
FDA (Drugs) · 2025-07-09
- ModerateTeva pitavastatin tablets recalled after failing impurity and degradation specifications
FDA (Drugs) · 2025-07-09
- ModerateCephalexin Oral Suspension Recalled for Failed Impurities Specifications
FDA (Drugs) · 2025-06-18
- ModerateCephalexin Oral Suspension Recalled for Failed Impurity Specifications
FDA (Drugs) · 2025-06-18